6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
body mass index; VTE ... = venous thromboembolism ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... actor for arterial thrombosis ... Age-appropriate cancer ... Age-appropriate cancer ... Workup #hematology #diagnosis
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
in Malignancy ... catheter-related thrombosis ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Microvascular thrombosis ... heart function (JVD ... Rarely performed Anticoagulation ... and recurrent VTE ... #management
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Non-Infectious (NTBE): • Malignancy ... Differential Diagnosis ... • Nonbacterial thrombotic ... cause + Systemic anticoagulation ... #management #cardiology